The authority will exercise complete management discretion over all operational blood system decisions. The domain of management discretion will include matters of health and safety with respect to the blood system. Decisions in this regard will be made within a health risk management framework which places on an equal footing the three critical elements of benefit, risk and cost. Members will have the authority to approve, upon the submission by the new blood services Board of Directors, the three-year corporate business plan, which includes its annual global budget and performance objectives, and a plan to allow for a contingency fund for emergencies, and, where necessary, to provide guidance to the Board on the contents of the plans. As members, they have the authority to appoint a Board of Directors.
New members can join the new authority with the unanimous consent of existing members.
Employees of the federal, provincial or territorial governments will not be eligible for appointment to the Board. Members will have the authority to require direct, external, comprehensive management audits and targeted special audits at their discretion. Should objectives for the blood program not be met satisfactorily, members will hold the Board accountable to take corrective action. Members will retain the power to remove some or all of the Board. Members will publish an annual report, including its audited financial statements.